Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses -13 M-12.6 M-12.9 M-13 M -51.5 M Research & development ———— — Operating income 224.7 M190.1 M148.9 M323.8 M 887.5 M Non-Operating Income, Total -103.2 M-103.4 M-93 M-102.1 M -401.7 M Interest expense, net of interest capitalized 104.4 M104.5 M102.9 M101.9 M 413.7 M Non-Operating Income, excl. Interest Expenses -208.8 M-209 M-205.8 M-203.8 M -827.4 M Unusual income/expense 1.2 M1.1 M9.9 M-200 K 12 M Pretax income 121.5 M86.7 M55.9 M221.7 M 485.8 M Equity in earnings ———— — Taxes 27.9 M25 M14.2 M59.4 M 126.5 M Non-controlling/minority interest ———— — After tax other income/expense -900 K-900 K-5.5 M2.7 M -4.6 M Net income before discontinued operations 93.6 M61.7 M41.7 M162.3 M 359.3 M Discontinued operations ———— — Net income 93.6 M61.7 M41.7 M162.3 M 359.3 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 93.6 M61.7 M41.7 M162.3 M 359.3 M Basic earnings per share (Basic EPS) 0.60.40.271.03 2.3 Diluted earnings per share (Diluted EPS) 0.60.390.271.03 2.29 Average basic shares outstanding 155.5 M155.8 M156.1 M155.9 M — Diluted shares outstanding 156.9 M156.8 M157 M157 M — EBITDA 480.9 M519.2 M553.3 M806 M 2.36 B EBIT 224.7 M190.1 M148.9 M323.8 M 887.5 M Cost of revenue 15.06 B14.48 B14.35 B15.86 B 59.75 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 256.2 M329.1 M404.4 M482.2 M 1.47 B